Science & Technology Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science & Technology Watch.

Press releases published on April 21, 2026

Apr. 21, 2026

Heifer International Welcomes Former Mali Minister Safia Boly to Lead Its Africa Programs

Indeterminate EIN Presswire

Apr. 21, 2026

Revolution Medicines to Present Updated Phase 1/2 Clinical Data for Daraxonrasib in First Line Metastatic Pancreatic Cancer Across Monotherapy and Combination Cohorts at the 2026 AACR Annual Meeting

Indeterminate GlobeNewswire

Apr. 21, 2026

Revolution Medicines to Present Preclinical Data on Innovative Mutant-Targeted Catalytic RAS(ON) Inhibitor at the 2026 AACR Annual Meeting

Indeterminate GlobeNewswire

Apr. 21, 2026

Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha-Targeting ADC at AACR Annual Meeting 2026

Indeterminate GlobeNewswire

Apr. 21, 2026

BBOT Presents Preclinical Data Showing RAS:PI3Kα Breaker BBO-10203 Inhibits PI3Kα/AKT Signaling in HER2AMP Models at the AACR Annual Meeting 2026

Indeterminate GlobeNewswire

Apr. 21, 2026

Matrix Service Company Sets Dates for Release of Third Quarter Fiscal 2026 Financial Results and Conference Call

Indeterminate GlobeNewswire

Apr. 21, 2026

Adswerve Named 2026 Adobe Customer Experience Orchestration Emerging Partner of the Year, Americas, for Third Consecutive Year

Indeterminate GlobeNewswire

Apr. 21, 2026

Society Pass Incorporated (Nasdaq: SOPA) Nasdaq delinquency notification letter (the “Notice”)

Indeterminate GlobeNewswire

Apr. 21, 2026

Isosceles Pharmaceuticals Announces First Patient Dosed in Phase I Clinical Trial of IPI201

Indeterminate EIN Presswire

Apr. 21, 2026

NowVertical Group Wins 2026 Google Cloud Data & Analytics Partner of the Year for Latin America

Indeterminate GlobeNewswire

Apr. 21, 2026

Aktis Oncology Announces Presentation of First Clinical Imaging and Dosimetry Data for AKY-2519 at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

Indeterminate GlobeNewswire

Apr. 21, 2026

Toll Brothers to Acquire Private Home Builder in Northwest Arkansas

Indeterminate GlobeNewswire

Apr. 21, 2026

ProstACT Global Phase 3 (Part 1) Selected as Late-Breaking Abstract at ASCO 2026

Indeterminate GlobeNewswire

Apr. 21, 2026

LESBIAN VISIBILITY WEEK CELEBRATES THE CURVE POWER LIST 2026: 75 LGBTQ+ WOMEN AND NONBINARY TRAILBLAZERS HONORED

Indeterminate EIN Presswire

Apr. 21, 2026

Canadian International Trade Tribunal Imposes Tariffs on Dumped, Foreign Steel Sold by Tenaris S.A. and Other Offshore Steel Pipe Exporters

Indeterminate GlobeNewswire

Apr. 21, 2026

Ascendis Announces Redemption of All $575 Million of Outstanding 2.25% Convertible Senior Notes Due 2028

Indeterminate GlobeNewswire

Apr. 21, 2026

Veeco Announces Date for First Quarter 2026 Financial Results and Conference Call

Indeterminate GlobeNewswire

Apr. 21, 2026

Rgenta Therapeutics Announces RGT-61159 Clinical Poster Presentation at the Upcoming 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

Indeterminate GlobeNewswire

Apr. 21, 2026

Fennec Pharmaceuticals Announces Acceptance of Abstracts at the 2026 ASCO Annual Meeting

Indeterminate GlobeNewswire

Apr. 21, 2026

Rapport Therapeutics Presents RAP-219 Focal Onset Seizure Phase 2a Follow-up Period Results Demonstrating Sustained Seizure Reduction at the 2026 American Academy of Neurology Annual Meeting

Indeterminate GlobeNewswire